circ-PSD3 promoted proliferation and invasion of papillary thyroid cancer cells via regulating the miR-7-5p/METTL7B axis

References

• Lim H, Devesa SS, Sosa JA, et al. Trends in thyroid cancer incidence and mortality in the United States, 1974–2013. JAMA. 2017;317(13):1338–1348.
   PubMed Web of Science ®Google Scholar
• Beebeejaun M, Chinnasamy E, Wilson P, et al. Papillary carcinoma of the thyroid in patients with primary hyperparathyroidism: is there a link? Med Hypotheses. 2017;103:100–104.
   PubMed Web of Science ®Google Scholar
• Correa P, Chen VW. Endocrine gland cancer. Cancer. 1995;75:338–352.
   PubMed Web of Science ®Google Scholar
• Qu S, Liu Z, Yang X, et al. The emerging functions and roles of circular RNAs in cancer. Cancer Lett. 2018;414:301–309.
   PubMed Web of Science ®Google Scholar
• Li S, Teng S, Xu J, et al. Microarray is an efficient tool for circRNA profiling. Brief Bioinform. 2019;20(4):1420–1433.
   PubMed Web of Science ®Google Scholar
• Xu H, Wang C, Song H, et al. RNA-Seq profiling of circular RNAs in human colorectal Cancer liver metastasis and the potential biomarkers. Mol Cancer. 2019;18(1):8–14.
   PubMedGoogle Scholar
• Meng S, Zhou H, Feng Z, et al. CircRNA: functions and properties of a novel potential biomarker for cancer. Mol Cancer. 2017;16(1):94–102.
   PubMed Web of Science ®Google Scholar
• Zhang HD, Jiang LH, Sun DW, et al. CircRNA: a novel type of biomarker for cancer. Breast Cancer. 2018;25(1):1–7.
   PubMed Web of Science ®Google Scholar
• Verduci L, Strano S, Yarden Y, et al. The circRNA-microRNA code: emerging implications for cancer diagnosis and treatment. Mol Oncol. 2019;13(4):669–680.
   PubMed Web of Science ®Google Scholar
• Zong L, Sun Q, Zhang H, et al. Increased expression of circRNA_102231 in lung cancer and its clinical significance. Biomed Pharmacother. 2018;102:639–644.
   PubMed Web of Science ®Google Scholar
• Huang X, Li Z, Zhang Q, et al. Circular RNA AKT3 upregulates PIK3R1 to enhance cisplatin resistance in gastric cancer via miR-198 suppression. Mol Cancer. 2019;18(1):71–91.
   PubMed Web of Science ®Google Scholar
• Chen L, Zhou H, Guan Z. CircRNA_000543 knockdown sensitizes nasopharyngeal carcinoma to irradiation by targeting miR-9/platelet-derived growth factor receptor B axis. Biochem Biophys Res Commun. 2019;512(4):786–792.
   PubMed Web of Science ®Google Scholar
• Zhao W, Dong M, Pan J, et al. Circular RNAs: A novel target among non‑coding RNAs with potential roles in malignant tumors . Mol Med Rep. 2019;20(4):3463–3474.
   PubMed Web of Science ®Google Scholar
• Chen Q, Liu T, Bao Y, et al. CircRNA cRAPGEF5 inhibits the growth and metastasis of renal cell carcinoma via the miR-27a-3p/TXNIP pathway. Cancer Lett. 2020;469:68–77.
   PubMed Web of Science ®Google Scholar
• Ma W, Zhao P, Zang L, et al. CircTP53 promotes the proliferation of thyroid cancer via targeting miR-1233-3p/MDM2 axis. J Endocrinol Invest. 2021;44(2):353–362.
   PubMed Web of Science ®Google Scholar
• Peng N, Shi L, Zhang Q, et al. Microarray profiling of circular RNAs in human papillary thyroid carcinoma. PLOS One. 2017;12(3):e0170287.
   PubMed Web of Science ®Google Scholar
• Zheng J, Luo J, Zeng H, et al. ( 125I suppressed the Warburg effect via regulating miR-338/PFKL axis in hepatocellular carcinoma . Biomed Pharmacother. 2019;119:109402.
   PubMed Web of Science ®Google Scholar
• Zeng H, Zheng J, Wen S, et al. MicroRNA-339 inhibits human hepatocellular carcinoma proliferation and invasion via targeting ZNF689. Drug Des Devel Ther. 2019;13:435–445.
   PubMed Web of Science ®Google Scholar
• Shang Q, Yang Z, Jia R, et al. The novel roles of circRNAs in human cancer. Mol Cancer. 2019;18(1):6–16.
   PubMed Web of Science ®Google Scholar
• Panda AC. Circular RNAs act as miRNA sponges. Adv Exp Med Biol. 2018;1087:67–79.
   PubMed Web of Science ®Google Scholar
• Horsham JL, Kalinowski FC, Epis MR, et al. Clinical potential of microRNA-7 in Cancer. J Clin Med. 2015;4(9):1668–1687.
   PubMed Web of Science ®Google Scholar
• Kalinowski FC, Brown RA, Ganda C, et al. microRNA-7: a tumor suppressor miRNA with therapeutic potential. Int J Biochem Cell Biol. 2014;54:312–317.
   PubMed Web of Science ®Google Scholar
• Pilarski R, Nagy R. Genetic testing by cancer site: endocrine system. Cancer J. 2012;18(4):364–371.
   PubMed Web of Science ®Google Scholar
• Ng WL, Mohd Mohidin TB, Shukla K. Functional role of circular RNAs in cancer development and progression. RNA Biol. 2018;15(8):995–1005.
   PubMed Web of Science ®Google Scholar
• Xia F, Chen Y, Jiang B, et al. Hsa_circ_0011385 accelerates the progression of thyroid cancer by targeting miR-361-3p. Cancer Cell Int. 2020;20:49–63.
   PubMed Web of Science ®Google Scholar
• Chen J, Li Y, Zheng Q, et al. Circular RNA profile identifies circPVT1 as a proliferative factor and prognostic marker in gastric cancer. Cancer Lett. 2017;388:208–219.
   PubMed Web of Science ®Google Scholar
• Chen B, Wei W, Huang X, et al. circEPSTI1 as a prognostic marker and mediator of triple-negative breast cancer progression. Theranostics. 2018;8(14):4003–4015.
   PubMed Web of Science ®Google Scholar
• Wang H, Yan X, Zhang H, et al. CircRNA circ_0067934 overexpression correlates with poor prognosis and promotes thyroid carcinoma progression. Med Sci Monit. 2019;25:1342–1349.
   PubMed Web of Science ®Google Scholar
• Liu J, Zheng X, Liu H. Hsa_circ_0102272 serves as a prognostic biomarker and regulates proliferation, migration and apoptosis in thyroid cancer. J Gene Med. 2020;22(9):e3209.
   PubMed Web of Science ®Google Scholar
• Su W, Wang Y, Wang F, et al. Hsa_circ_0005379 regulates malignant behavior of oral squamous cell carcinoma through the EGFR pathway. BMC Cancer. 2019;19(1):400–413.
   PubMedGoogle Scholar
• Yang F, Hu A, Li D, et al. Circ-HuR suppresses HuR expression and gastric cancer progression by inhibiting CNBP transactivation. Mol Cancer. 2019;18(1):158–174.
   PubMed Web of Science ®Google Scholar
• Shen Z, Zhou L, Zhang C, et al. Reduction of circular RNA Foxo3 promotes prostate cancer progression and chemoresistance to docetaxel. Cancer Lett. 2020;468:88–101.
   PubMed Web of Science ®Google Scholar
• Yang Y, Ding L, Li Y, et al. Hsa_circ_0039411 promotes tumorigenesis and progression of papillary thyroid cancer by miR-1179/ABCA9 and miR-1205/MTA1 signaling pathways. J Cell Physiol. 2020;235(2):1321–1329.
   PubMed Web of Science ®Google Scholar
• Pan Y, Xu T, Liu Y, et al. Upregulated circular RNA circ_0025033 promotes papillary thyroid cancer cell proliferation and invasion via sponging miR-1231 and miR-1304. Biochem Biophys Res Commun. 2019;510(2):334–338.
   PubMed Web of Science ®Google Scholar
• Tang Q, Hann SS. Biological roles and mechanisms of circular RNA in human cancers. Onco Targets Ther. 2020;13:2067–2092.
   PubMed Web of Science ®Google Scholar
• Yao Y, Chen X, Yang H, et al. Hsa_circ_0058124 promotes papillary thyroid cancer tumorigenesis and invasiveness through the NOTCH3/GATAD2A axis. J Exp Clin Cancer Res. 2019;38(1):318–336.
   PubMedGoogle Scholar
• Ye M, Hou H, Shen M, et al. Circular RNA circFOXM1 plays a role in papillary thyroid carcinoma by sponging miR-1179 and regulating HMGB1 expression. Mol Ther Nucleic Acids. 2020;19:741–750.
   PubMedGoogle Scholar
• Lima CR, Gomes CC, Santos MF. Role of microRNAs in endocrine cancer metastasis. Mol Cell Endocrinol. 2017;456:62–75.
   PubMed Web of Science ®Google Scholar
• Hua K, Jin J, Zhang H, et al. MicroRNA-7 inhibits proliferation, migration and invasion of thyroid papillary cancer cells via targeting CKS2. Int J Oncol. 2016;49(4):1531–1540.
   PubMed Web of Science ®Google Scholar
• Han JY, Guo S, Wei N, et al. ciRS-7 promotes the proliferation and migration of papillary thyroid cancer by negatively regulating the miR-7/epidermal growth factor receptor axis. Biomed Res Int. 2020;2020:9875636.
   PubMed Web of Science ®Google Scholar
• Cai WY, Chen X, Chen LP, et al. Role of differentially expressed genes and long non-coding RNAs in papillary thyroid carcinoma diagnosis, progression, and prognosis. J Cell Biochem. 2018;119(10):8249–8259.
   PubMed Web of Science ®Google Scholar
• McKinnon CM, Mellor H. The tumor suppressor RhoBTB1 controls Golgi integrity and breast cancer cell invasion through METTL7B. BMC Cancer. 2017;17(1):145–154.
   PubMedGoogle Scholar
• Liu D, Li W, Zhong F, et al. METTL7B is required for cancer cell proliferation and tumorigenesis in non-small cell lung cancer. Front Pharmacol. 2020;11(178-189).
   Google Scholar
• Neilsen PM, Noll JE, Suetani RJ, et al. Mutant p53 uses p63 as a molecular chaperone to alter gene expression and induce a pro-invasive secretome. Oncotarget. 2011;2(12):1203–1217.
   PubMed Web of Science ®Google Scholar